| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
49,483 |
45,385 |
$2.84M |
| L0650 |
Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf |
1,236 |
1,186 |
$874K |
| 95913 |
|
2,644 |
2,271 |
$566K |
| 01936 |
|
5,347 |
4,221 |
$539K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,254 |
12,351 |
$538K |
| 95886 |
|
2,747 |
2,325 |
$359K |
| 64483 |
|
2,681 |
2,210 |
$330K |
| 01992 |
|
2,715 |
2,118 |
$299K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,064 |
1,917 |
$175K |
| 98941 |
Chiropractic manipulative treatment; spinal, 3-4 regions |
4,221 |
1,541 |
$172K |
| 64635 |
|
623 |
465 |
$154K |
| 64636 |
|
593 |
438 |
$77K |
| 01938 |
|
626 |
477 |
$75K |
| 62321 |
|
363 |
304 |
$60K |
| 64493 |
|
373 |
294 |
$56K |
| 98943 |
|
1,359 |
472 |
$46K |
| 62323 |
|
174 |
167 |
$39K |
| 20550 |
|
464 |
195 |
$30K |
| 01991 |
|
368 |
306 |
$28K |
| 01940 |
|
253 |
190 |
$27K |
| 64494 |
|
359 |
274 |
$27K |
| 27096 |
|
141 |
132 |
$27K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
96 |
74 |
$24K |
| L0180 |
Cervical, multiple post collar, occipital/mandibular supports, adjustable |
90 |
88 |
$21K |
| 01935 |
|
170 |
140 |
$16K |
| 20553 |
|
301 |
232 |
$15K |
| 20611 |
|
271 |
203 |
$14K |
| 20610 |
|
429 |
374 |
$13K |
| 64633 |
|
70 |
52 |
$12K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
122 |
45 |
$9K |
| 90837 |
Psychotherapy, 53 minutes with patient |
124 |
98 |
$9K |
| 01937 |
|
105 |
82 |
$9K |
| 99215 |
Prolong outpt/office vis |
102 |
96 |
$8K |
| 97012 |
|
479 |
223 |
$8K |
| 64490 |
|
27 |
26 |
$7K |
| 64634 |
|
66 |
52 |
$7K |
| 90834 |
Psychotherapy, 45 minutes with patient |
102 |
90 |
$6K |
| L1833 |
Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated, off-the shelf |
18 |
13 |
$5K |
| 64484 |
|
112 |
92 |
$5K |
| 98940 |
|
162 |
76 |
$5K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,541 |
1,398 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,416 |
2,991 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
38 |
38 |
$3K |
| 99442 |
|
211 |
197 |
$3K |
| 64491 |
|
13 |
12 |
$2K |
| 99443 |
|
90 |
87 |
$2K |
| 64495 |
|
34 |
24 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
28 |
15 |
$1K |
| 90791 |
Psychiatric diagnostic evaluation |
13 |
13 |
$1K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,833 |
1,600 |
$751.73 |
| 77002 |
|
46 |
28 |
$584.71 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
26 |
25 |
$386.08 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
62 |
56 |
$375.60 |
| 99441 |
|
14 |
12 |
$93.51 |
| J3490 |
Unclassified drugs |
69 |
61 |
$86.10 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
56 |
55 |
$35.40 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
970 |
704 |
$0.00 |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
104 |
99 |
$0.00 |